| |
|
|
|
|
|
|
|||
|
Blood, 28 May 2009, Vol. 113, No. 22, pp. 5628-5634. Prepublished online as a Blood First Edition Paper on March 27, 2009; DOI 10.1182/blood-2008-12-197467.
Submitted December 31, 2008
Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, United States * Corresponding author; email: mille011{at}umn.edu.
We examined the clinical impact of killer-immunoglobulin receptor-ligand (KIR-L) mismatch in 257 recipients of single (n=91) or double (n=166) unit umbilical cord blood (UCB) grafts following myeloablative (n=155) or reduced intensity (n=102) conditioning regimens. Analyses of double unit grafts considered the KIR-L match status of the dominant engrafting unit. After myeloablative conditioning, KIR-L mismatch had no effect on grade III-IV acute acute graft-versus-host disease (GVHD), transplant-related mortality (TRM), relapse and survival. In contrast, following reduced intensity conditioning, KIR-L mismatch between the engrafted unit and the recipient resulted in significantly higher rates of grade III-IV acute GVHD (42% [CI, 27-59) vs. 13% [CI, 5-21], p < .01) and TRM (27% [CI, 12-42%] vs. 12% [CI, 5-19%], p=.03) with inferior survival (32% [CI, 15-59%] vs. 52% [CI, 47-67%], p=.03). Multivariate analysis identified KIR-L mismatch as the only predictive factor associated with the development of grade III-IV acute GVHD (RR 1.8, CI [1.1-2.9]; p=.02) and demonstrated a significant association between KIR-L mismatch and increased risk of death (RR 1.8, 95%CI, 1.0-3.1, p=.05). Our results do not support the selection of UCB units based on KIR-L status and suggest that KIR-L mismatching should be avoided in reduced intensity UCB transplantation.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||